Innovations in Cardio-oncology Resulting from the COVID-19 Pandemic.
Curr Treat Options Oncol
; 23(9): 1288-1302, 2022 09.
Article
in English
| MEDLINE | ID: covidwho-2232026
ABSTRACT
OPINION STATEMENT The COVID pandemic has transformed our approach to patient care, research, and training in cardio-oncology. While the early phases of the COVID pandemic were exceptionally frightening, we now can reflect on the innovative changes that brought more effective and patient-centered care to our doorsteps:
expansion of telemedicine, integration of digital health, wider adoption of cardiac biomarkers, consolidation, and coordination of cardio-oncology testing. Normally, it takes years for health care systems to adopt new technology or modify patient care pathways; however, COVID pushed healthcare providers and the health systems to change at warp speed. All of these innovations have improved our efficacy and provided a more "patient-centered" approach for our cardio-oncology patients. The changes we have made in cardio-oncology will likely remain well beyond the pandemic and continue to grow improving the cardiovascular care of oncology patients.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Curr Treat Options Oncol
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
S11864-022-00997-7
Similar
MEDLINE
...
LILACS
LIS